| Not Yet Recruiting | Adoption of Audio Recording in the Outpatient Supportive Care Center NCT04871477 | M.D. Anderson Cancer Center | — |
| Withdrawn | Itacitinib for the Treatment Steroid Refractory Immune Related Adverse Events Arising From Immune Checkpoint I NCT05660421 | Douglas Johnson | Phase 2 |
| Recruiting | A Study of the Drug Letermovir as Prevention of Cytomegalovirus Infection After Stem Cell Transplant in Pediat NCT05711667 | Children's Oncology Group | Phase 3 |
| Withdrawn | Virtual Reality for the Improvement of Patients Understanding of Disease and Treatment (MRgRT) NCT05600556 | Thomas Jefferson University | N/A |
| Recruiting | Alteplase Through an Indwelling Pleural Catheter for the Management of Symptomatic Septated Malignant Pleural NCT06184321 | M.D. Anderson Cancer Center | EARLY_Phase 1 |
| Recruiting | Weighted Blanket Use to Reduce Anxiety in Oncology Patients NCT06089408 | Ohio State University Comprehensive Cancer Center | N/A |
| Recruiting | Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers NCT05663502 | AIDS Malignancy Consortium | — |
| Recruiting | Vertebroplasty With Radiation Therapy for Spine Metastatic Cancer Patients With Indeterminate Lesion (SINS Cri NCT05178472 | Ohio State University Comprehensive Cancer Center | N/A |
| Recruiting | Study Assessing the Feasibility, Safety and Efficacy of Genetically Engineered Glucocorticoid Receptor Knock O NCT05101213 | M.D. Anderson Cancer Center | Phase 1 |
| Recruiting | Mobile App to Help Survivors of Childhood Cancer Navigate Long-Term Follow-Up Care NCT05641961 | University of California, San Francisco | N/A |
| Active Not Recruiting | Vincristine Pharmacokinetics in Infants NCT05359237 | Children's Oncology Group | — |
| Completed | Psilocybin Combined With Multidisciplinary Palliative Care in Demoralized Cancer Survivors With Chronic Pain NCT05506982 | Emory University | Phase 1 |
| Completed | Interactive Survivorship Program for the Improvement of Healthcare Resources in Adolescent and Young Adult Can NCT04593277 | Fred Hutchinson Cancer Center | N/A |
| Terminated | Cord Blood Transplant With Dilanubicel for the Treatment of HIV Positive Hematologic Cancers NCT04083170 | Fred Hutchinson Cancer Center | Phase 2 |
| Recruiting | Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection NCT05334069 | Alliance for Clinical Trials in Oncology | — |
| Withdrawn | 64Cu-DOTA-pembrolizumab PET for the Study of PD1 Expression NCT04605614 | City of Hope Medical Center | Phase 1 |
| Withdrawn | Ipilimumab, Ibrutinib, and Nivolumab for the Treatment of Chronic Lymphocytic Leukemia and Richter Transformat NCT04781855 | M.D. Anderson Cancer Center | Phase 1 |
| Active Not Recruiting | A Mobile Application, Oncpatient, to Assist Patients Undergoing Radiation Therapy NCT05173961 | City of Hope Medical Center | N/A |
| Active Not Recruiting | The Effect of Exercise and Nicotinamide Riboside Muscle Health and Insulin Resistance in Survivors of Childhoo NCT05023993 | City of Hope Medical Center | N/A |
| Active Not Recruiting | Reproducibility and Accuracy of a Portable System for Early Detection of Cardiac Dysfunction in Childhood Canc NCT05138991 | City of Hope Medical Center | N/A |
| Active Not Recruiting | Testing Counseling and Mobile Health Interventions to Improve Physical Activity and Diet Quality in Survivors NCT05075759 | Fred Hutchinson Cancer Center | N/A |
| Withdrawn | Olanzapine for the Treatment of Chronic Nausea and/or Vomiting in Patients With Advanced Cancer NCT05403580 | Mayo Clinic | Phase 3 |
| Active Not Recruiting | PEA for the Relief of Chemotherapy-Induced Peripheral Neuropathy NCT05246670 | Academic and Community Cancer Research United | Phase 2 |
| Active Not Recruiting | Infusion of Expanded Cord Blood Cells in Addition to Single Cord Blood Transplant in Treating Patients With Ac NCT03399773 | Fred Hutchinson Cancer Center | Phase 2 |
| Active Not Recruiting | An Observational Research Study for Cancer Patients on Immune Checkpoint Inhibitors, DiRECT Study NCT05364086 | University of Rochester NCORP Research Base | — |
| Terminated | Using Technology to Optimize Collaborative Care Management of Depression in Urban and Rural Cancer Centers, SC NCT05012124 | University of Washington | N/A |
| Active Not Recruiting | Pegloticase for the Reduction of Uric Acid in Patients With Tumor Lysis Syndrome NCT04745910 | M.D. Anderson Cancer Center | Phase 4 |
| Recruiting | The Longitudinal Impact of Respiratory Viruses on Bronchiolitis Obliterans Syndrome After Allogeneic Hematopoi NCT05250037 | Fred Hutchinson Cancer Center | — |
| Active Not Recruiting | Testing the Effects of Exercise on Chemotherapy-Induced Peripheral Neuropathy NCT04888988 | University of Rochester NCORP Research Base | N/A |
| Terminated | Pharmacokinetics of Sotrovimab as Pre-exposure Prophylaxis for COVID-19 in Hematopoietic Stem Cell Transplant NCT05135650 | Fred Hutchinson Cancer Center | Phase 1 |
| Active Not Recruiting | Olanzapine Versus Megestrol Acetate for the Treatment of Loss of Appetite Among Advanced Cancer Patients NCT04939090 | Alliance for Clinical Trials in Oncology | Phase 3 |
| Terminated | Omacetaxine and Venetoclax for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplast NCT04874194 | M.D. Anderson Cancer Center | Phase 1 / Phase 2 |
| Completed | Remote Monitoring in Cancer Care: A Platform Study NCT05018208 | Mayo Clinic | — |
| Completed | Yoga Intervention for the Improvement of Cancer-Related Stress in Cancer Survivors NCT04754529 | Roswell Park Cancer Institute | N/A |
| Withdrawn | Perception of Cure Among Patients With Metastatic Cancer NCT04820894 | City of Hope Medical Center | — |
| Active Not Recruiting | Financial Navigation Program to Improve Understanding and Management of Financial Aspects of Cancer Care for P NCT04960787 | SWOG Cancer Research Network | N/A |
| Recruiting | Baloxavir and Oseltamivir for the Treatment of Severe Influenza Infection in Immunocompromised Patients NCT04712539 | M.D. Anderson Cancer Center | Phase 2 |
| Completed | An Educational Intervention on Provider Knowledge for the Support of Cancer Survivors NCT06062901 | Ohio State University Comprehensive Cancer Center | N/A |
| Terminated | eHealth Diet and Physical Activity Program for the Improvement of Health in Rural Latino Cancer Survivors NCT04081298 | Fred Hutchinson Cancer Center | N/A |
| Completed | PHASE II SINGLE-CENTER, RANDOMIZED, OPEN-LABEL, PROSPECTIVE, STUDY TO DETERMINE THE IMPACT OF SERIAL PROCALCIT NCT04983901 | M.D. Anderson Cancer Center | Phase 2 |
| Completed | Understanding the Risk of Blood Clots and Bleeding in Patients With Hematological Malignancies, HAT Study NCT05053100 | Mayo Clinic | — |
| Completed | Measuring the Impact of MANNA s Medically Tailored Meal Program in Patients With a Non-terminal Cancer Diagnos NCT05118802 | Thomas Jefferson University | — |
| Completed | Cancer Pain Rehabilitation Program to Reduce Pain Related Distress, and Reliance of Pain Medication Through Mu NCT05036408 | City of Hope Medical Center | N/A |
| Completed | Telehealth Exercise Platform to Reduce Frailty After Bone Marrow Transplant NCT04968119 | City of Hope Medical Center | N/A |
| Recruiting | Comparing Brief Behavioral Therapy (BBT-CI) and Healthy Eating Education Learning (HEAL) for Cancer-Related Sl NCT04829539 | University of Rochester NCORP Research Base | Phase 3 |
| Completed | Use of Google Translate to Enhance Patient Pain and Nausea Assessment and Satisfaction After General Anesthesi NCT05060328 | M.D. Anderson Cancer Center | — |
| Terminated | Multicomponent Physical Activity Intervention for the Reduction of Psychosocial Distress in Cancer Patients NCT05056831 | M.D. Anderson Cancer Center | N/A |
| Completed | Geriatric Optimization Plan to Improve Survival in Older Adult Allogeneic Hematopoietic Cell Transplant Candid NCT05972577 | Ohio State University Comprehensive Cancer Center | N/A |
| Active Not Recruiting | A Multidisciplinary Approach to Improve the Health of Older Adults With Blood Cancers After Stem Cell Transpla NCT04914338 | City of Hope Medical Center | N/A |
| Active Not Recruiting | Patient Perceptions of the Relational Empathy of Healthcare Practitioners From the Department of Emergency Med NCT05102656 | M.D. Anderson Cancer Center | N/A |
| Recruiting | Social Relationships and Accelerated Aging in Hematopoietic Cell Transplant Survivors NCT04892823 | Medical College of Wisconsin | — |
| Completed | Positive Activities Intervention to Improve Quality of Life in Collectivist Culture Cancer Patients and Their NCT04810052 | M.D. Anderson Cancer Center | N/A |
| Withdrawn | Thermal Therapy for the Treatment of Depression in Cancer Survivors, the S-WARM Study NCT04803630 | Roswell Park Cancer Institute | EARLY_Phase 1 |
| Suspended | Assessment of Verbal Comprehension and Cognitive Processes in Patients Admitted to the Palliative and Supporti NCT05091632 | M.D. Anderson Cancer Center | — |
| Withdrawn | Lopinavir/Ritonavir for the Treatment of COVID-19 Positive Patients With Cancer and Immune Suppression in the NCT04455958 | OHSU Knight Cancer Institute | Phase 2 |
| Suspended | Human Lysozyme Goat Milk for the Prevention of Graft Versus Host Disease in Patients With Blood Cancer Undergo NCT04177004 | City of Hope Medical Center | Phase 1 |
| Completed | Distress Associated with Coronavirus Disease 2019 and Telehealth on Supportive Care Patients with Advanced Can NCT05058339 | M.D. Anderson Cancer Center | — |
| Active Not Recruiting | Survey Assessment of Patient and Provider Impressions of Telemedicine in Radiation Oncology NCT05496972 | M.D. Anderson Cancer Center | — |
| Recruiting | Formulating Expert Consensus Guidelines in Cancer Care Using the Delphi Method NCT05054413 | M.D. Anderson Cancer Center | — |
| Recruiting | Outcomes After Chimeric Antigen Receptor Therapy and Radiation Therapy for Hematologic Malignancies NCT04888338 | M.D. Anderson Cancer Center | — |
| Terminated | DS-1594b With or Without Azacitidine, Venetoclax, or Mini-HCVD for the Treatment of Relapsed or Refractory Acu NCT04752163 | M.D. Anderson Cancer Center | Phase 1 / Phase 2 |
| Completed | Virtual Reality Experiences for Anxiety and Pain Control NCT04759183 | OHSU Knight Cancer Institute | N/A |
| Completed | Study of Attention and Memory Treatments for Cancer Survivors NCT04870320 | University of California, San Francisco | N/A |
| Completed | Cannabis Use Patterns Among Cancer Patients NCT05132842 | Thomas Jefferson University | — |
| Recruiting | Addition of Cord Blood Tissue-Derived Mesenchymal Stromal Cells to Ruxolitinib for the Treatment of Steroid-Re NCT04744116 | M.D. Anderson Cancer Center | EARLY_Phase 1 |
| Active Not Recruiting | Patient Reported Symptom Control With THC or CBD Use NCT04875286 | M.D. Anderson Cancer Center | — |
| Withdrawn | Testing the Combination of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) in Children, Adolescent, and You NCT04500548 | National Cancer Institute (NCI) | Phase 1 |
| Terminated | Bintrafusp Alfa and Pimasertib for the Treatment of Patients With Brain Metastases NCT04789668 | M.D. Anderson Cancer Center | Phase 1 / Phase 2 |
| Terminated | Infliximab and Intravenous Immunoglobulin Therapy in Treating Patients With Steroid-Refractory Pneumonitis NCT04438382 | ECOG-ACRIN Cancer Research Group | Phase 2 |
| Completed | Leflunomide for the Treatment of Severe COVID-19 in Patients With a Concurrent Malignancy NCT04532372 | City of Hope Medical Center | Phase 1 / Phase 2 |
| Completed | Impact of Aminoglycosides in Hypotensive Septic Oncology Patients NCT05045963 | M.D. Anderson Cancer Center | — |
| Completed | Viral Specific T Cell Therapy for COVID-19 Related Pneumonia NCT04742595 | M.D. Anderson Cancer Center | EARLY_Phase 1 |
| Active Not Recruiting | Acalabrutinib for the Treatment of Chronic Graft Versus Host Disease NCT04198922 | Fred Hutchinson Cancer Center | Phase 2 |
| Active Not Recruiting | Mobile Health and Social Media Physical Activity Intervention Among Adolescent and Young Adult Childhood Cance NCT04089358 | Children's Oncology Group | Phase 3 |
| Active Not Recruiting | Parental Attitudes and Beliefs Regarding Risks Associated With Opioid Use in Children With Cancer NCT05055011 | M.D. Anderson Cancer Center | — |
| Withdrawn | Palliative, Rehabilitation, and Integrated Medicine Handbook for Self Care at Work NCT05038384 | M.D. Anderson Cancer Center | — |
| Active Not Recruiting | Cardiovascular Reserve Evaluation in Survivors of Transplant, CREST Study NCT04537871 | City of Hope Medical Center | — |
| Terminated | Rintatolimod and IFN Alpha-2b for the Treatment of COVID-19 in Cancer Patients NCT04379518 | Roswell Park Cancer Institute | Phase 1 / Phase 2 |
| Completed | Rose Geranium in Sesame Oil Nasal Spray for the Improvement of Nasal Vestibulitis Symptoms in Cancer Patients NCT04620369 | Mayo Clinic | Phase 3 |
| Recruiting | Exercise Program (TEAM Me) for the Improvement of Movement and Mobility in Pediatric and Adolescent and Young NCT04678427 | M.D. Anderson Cancer Center | N/A |
| Recruiting | The Impact of COVID-19 on Pulmonary Procedures NCT05022446 | M.D. Anderson Cancer Center | — |
| Completed | Self-Management Program and Survivorship Care Plan in Improving the Health of Cancer Survivors After Stem Cell NCT03125070 | Fred Hutchinson Cancer Center | Phase 3 |
| Active Not Recruiting | Fentanyl Buccal Tablet or Morphine for Exertional Dyspnea in Cancer Patients NCT04188418 | M.D. Anderson Cancer Center | Phase 3 |
| Completed | Ibrutinib for the Treatment of COVID-19 in Patients Requiring Hospitalization NCT04439006 | Jennifer Woyach | Phase 1 |
| Completed | Predicting the Impact of Treatment Toxicities on Health During Cancer ( PATTERN ) NCT05790538 | OHSU Knight Cancer Institute | — |
| Completed | SARS-CoV-2 Donor-Recipient Immunity Transfer NCT04666025 | City of Hope Medical Center | — |
| Withdrawn | Itacitinib for the Prevention of Graft Versus Host Disease in Patients Undergoing Donor Stem Cell Transplantat NCT04127721 | M.D. Anderson Cancer Center | Phase 2 |
| Active Not Recruiting | Financial Toxicity in Cancer Patients NCT04592250 | M.D. Anderson Cancer Center | — |
| Active Not Recruiting | Effect of Opioid Infusion Rate on Abuse Liability Potential of Intravenous Hydromorphone for Cancer Pain NCT04296305 | M.D. Anderson Cancer Center | Phase 4 |
| Completed | Shared Healthcare Actions and Reflections Electronic Systems in Survivorship NCT04337203 | Wake Forest University Health Sciences | N/A |
| Withdrawn | Autophagy Activation for the Alleviation of Cardiomyopathy Symptoms After Anthracycline Treatment, ATACAR Tria NCT04190433 | Mayo Clinic | Phase 2 |
| Completed | Expanded Evaluation of the Survivorship Wellness Group Program in the Context of COVID-19 and Telehealth NCT04630015 | University of California, San Francisco | — |
| Active Not Recruiting | Prospective Exploratory Study of FAPi PET/CT With Histopathology Validation in Patients With Various Cancers NCT04459273 | Jonsson Comprehensive Cancer Center | Phase 1 |
| Recruiting | Impact of Project ECHO on Improving the Quality of Palliative Care in Patients With Advanced Cancer and Their NCT04984551 | M.D. Anderson Cancer Center | Phase 2 |
| Active Not Recruiting | Telementoring Intervention (ECHO) for the Transformation of Professional Engagement, Practice Efficiency, and NCT04196972 | M.D. Anderson Cancer Center | N/A |
| Recruiting | Expressive Writing for the Management of Stress in Cancer Survivors NCT04776941 | M.D. Anderson Cancer Center | N/A |
| Completed | Perioperative Care in the Cancer Patient -1, ARCA-1 Study NCT04491409 | M.D. Anderson Cancer Center | — |
| Recruiting | Study of Cord Blood Derived Mesenchymal Stem Cells for Treatment of Moderate, Severe or Critical Pneumonia NCT04565665 | M.D. Anderson Cancer Center | Phase 1 / Phase 2 |
| Completed | Anakinra for the Reduction of CAR-T Toxicity in Patients With Relapsed or Refractory Large B-cell Lymphoma NCT04432506 | M.D. Anderson Cancer Center | Phase 2 |
| Recruiting | Donor Bone Marrow Derived Mesenchymal Stem Cells in Controlling Heart Failure in Patients With Cardiomyopathy NCT02962661 | M.D. Anderson Cancer Center | Phase 1 |
| Completed | Effect of the COVID-19 Public Health Crisis on the Mental Health and Physical Well-Being of Cancer Patients, t NCT04652505 | M.D. Anderson Cancer Center | — |
| Recruiting | The Effect of COVID-19 Pandemic on Adolescent and Young Adult Cancer Patients and Survivors NCT04551378 | M.D. Anderson Cancer Center | — |
| Withdrawn | Major Complication Rate in Cancer Patients With Neutropenic Fever Potentially Eligible for a Hospital at Home NCT04557709 | M.D. Anderson Cancer Center | — |
| Recruiting | Duloxetine and Neurofeedback Training for the Treatment of Chemotherapy Induced Peripheral Neuropathy NCT04560673 | M.D. Anderson Cancer Center | Phase 2 |
| Recruiting | Increasing Knowledge and Interest in Cancer Clinical Trials NCT06501040 | Hayley Thompson | N/A |
| Active Not Recruiting | Well-Being and Health-Related Quality of Life in Cancer Patients and Survivors During the COVID-19 Pandemic NCT04500600 | M.D. Anderson Cancer Center | — |
| Terminated | Tocilizumab for Patients With Cancer and COVID-19 Disease NCT04370834 | National Cancer Institute (NCI) | Phase 2 |
| Active Not Recruiting | Well-being in Cancer Patients With Neuropathy During COVID-19 Who Participated in Prior Clinical Trials NCT04650178 | M.D. Anderson Cancer Center | — |
| Active Not Recruiting | Evaluation of Association Between Testosterone Levels, Dementia, and Adverse Mental Health Outcomes NCT04743466 | M.D. Anderson Cancer Center | — |
| Withdrawn | Psycho-Educational Cognition Intervention in Patients With Blood and Lymph Cancer NCT03804164 | City of Hope Medical Center | N/A |
| Completed | Geriatric Assessment Screening Tool for the Identification of At-Risk Older Adults Who Are Undergoing Cancer T NCT04788758 | Thomas Jefferson University | N/A |
| Recruiting | Neurocognitive Outcomes After Whole Brain Radiation Therapy for Hematologic Malignancies NCT05011045 | M.D. Anderson Cancer Center | — |
| Active Not Recruiting | Triplex Vaccine in Preventing CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplantation NCT04060277 | City of Hope Medical Center | Phase 2 |
| Completed | Development of the Oncology Opportunity Cost Assessment Tool NCT04694911 | Thomas Jefferson University | — |
| Active Not Recruiting | Understanding Challenges, Behavioral Patterns, and Preferences Toward Participation in Clinical Trials in Mino NCT04630431 | Mayo Clinic | N/A |
| Completed | Close Assessment and Testing for Chronic Graft Versus Host Disease, CATCH Study NCT04188912 | Fred Hutchinson Cancer Center | — |
| Recruiting | Role of Gut Microbiome in Cancer Therapy NCT05112614 | Mayo Clinic | — |
| Terminated | Nozin in Preventing Respiratory Viral Infections in Patients Undergoing Stem Cell Transplant, PREV-NOSE STUDY NCT04060849 | Fred Hutchinson Cancer Center | Phase 1 |
| Terminated | Identifying Best Approach in Improving Quality of Life and Survival After a Donor Stem Cell Transplant in Olde NCT03870750 | Fred Hutchinson Cancer Center | Phase 2 / Phase 3 |
| Completed | Whole Body Vibration for the Improvement of Health and Functioning in Participants With Chemotherapy-Induced P NCT04170075 | OHSU Knight Cancer Institute | N/A |
| Recruiting | Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorde NCT03816345 | National Cancer Institute (NCI) | Phase 1 |
| Recruiting | 211At-BC8-B10 Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory High-Ris NCT03670966 | Fred Hutchinson Cancer Center | Phase 1 / Phase 2 |
| Active Not Recruiting | CBM588 in Improving Clinical Outcomes in Patients Who Have Undergone Donor Hematopoietic Stem Cell Transplant NCT03922035 | City of Hope Medical Center | Phase 1 |
| Terminated | Impact of Phone Call About Financial Reimbursement Program on Access to Cancer Clinical Trials NCT03943082 | University of California, San Francisco | N/A |
| Recruiting | Complications and Clinical Response in Cancer Patients Treated With Anti-VEGF-Related Therapies NCT05108519 | M.D. Anderson Cancer Center | — |
| Completed | Enhanced, EHR-facilitated Cancer Symptom Control Pragmatic Clinical Trial NCT03892967 | Mayo Clinic | N/A |
| Active Not Recruiting | Hu8F4 in Treating Patients With Advanced Hematologic Malignancies NCT02530034 | M.D. Anderson Cancer Center | Phase 1 |
| Withdrawn | Human Lysozyme Goat Milk in Treating Patients With Blood Cancer Undergoing Donor Stem Cell Transplant NCT03531281 | City of Hope Medical Center | Phase 1 |
| Completed | Fecal Microbiota Transplantation for Steroid Resistant/Dependent Acute GI GVHD NCT03812705 | Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | Phase 2 |
| Terminated | Levorphanol as a Second Line Opioid in Reducing Pain in Patients With Cancer NCT03579446 | M.D. Anderson Cancer Center | EARLY_Phase 1 |
| Completed | 2-Step Approach to Stem Cell Transplant in Treating Participants With Hematological Malignancies NCT03712878 | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | Phase 2 |
| Completed | Risk of Chemotherapy Toxicity in Older Patients With Blood Cancer or Non-small Cell Lung Cancer NCT05106374 | Ohio State University Comprehensive Cancer Center | — |
| Active Not Recruiting | CMV-MVA Triplex Vaccination of Stem Cell Donors in Preventing CMV Viremia in Participants With Allogeneic Tran NCT03560752 | City of Hope Medical Center | Phase 1 |
| Recruiting | Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease NCT03425526 | M.D. Anderson Cancer Center | Phase 1 |
| Withdrawn | Patient-Driven Transfusion Thresholds in Hematological Disorders: A Pilot Study NCT03086252 | Emory University | N/A |
| Completed | Apixaban in Preventing Secondary Cancer Related Venous Thrombosis in Cancer Patients Who Have Completed Antico NCT03080883 | Academic and Community Cancer Research United | Phase 3 |
| Active Not Recruiting | Atezolizumab in Treating Patients With Cancer Following Adoptive Cell Transfer NCT02862275 | National Cancer Institute (NCI) | Phase 1 |
| Active Not Recruiting | Ropidoxuridine and Whole Brain Radiation Therapy in Treating Patients With Brain Metastases NCT02993146 | National Cancer Institute (NCI) | Phase 1 |
| Active Not Recruiting | Gardasil 9 Vaccine in Preventing HPV Infection in Patients With Hematologic Malignancies Undergoing Donor Stem NCT03023631 | M.D. Anderson Cancer Center | Phase 4 |
| Recruiting | Collection of Immunology Specimens From Patients With Cancer or Blood Disorders, and Healthy Volunteers NCT03207854 | University of Southern California | — |
| Active Not Recruiting | Testing AZD1775 as a Potential Targeted Treatment in Cancers With BRCA Genetic Changes (MATCH-Subprotocol Z1I) NCT04439227 | National Cancer Institute (NCI) | Phase 2 |
| Completed | A Two Step Approach to Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Hematologic Malign NCT03032783 | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | Phase 2 |
| Active Not Recruiting | Comprehensive Nutritional Geriatric Assessments in Identifying Malnutrition in Older Cancer Participants NCT03035604 | M.D. Anderson Cancer Center | — |
| Completed | Identifying, Understanding, and Overcoming Barriers to the Use of Clinical Practice Guidelines in Pediatric On NCT02847130 | Children's Oncology Group | — |
| Active Not Recruiting | Preliminary Testing of the MD Anderson Symptom Inventory (Adolescent Version) NCT02515383 | M.D. Anderson Cancer Center | — |
| Completed | Exercise Prehab in Older Adults With Hematologic Malignancies NCT02791737 | Ohio State University Comprehensive Cancer Center | N/A |
| Active Not Recruiting | Busulfan, Fludarabine Phosphate, and Post-Transplant Cyclophosphamide in Treating Patients With Blood Cancer U NCT02861417 | M.D. Anderson Cancer Center | Phase 2 |
| Completed | Fructooligosaccharides in Treating Patients With Blood Cancer Undergoing Donor Stem Cell Transplant NCT02805075 | Stanford University | Phase 1 |
| Active Not Recruiting | Testing Binimetinib as a Potential Targeted Treatment in Cancers With NRAS Genetic Changes (MATCH-Subprotocol NCT04439344 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Testing AZD4547 as a Potential Targeted Treatment in Cancers With FGFR Genetic Changes (MATCH-Subprotocol W) NCT04439240 | National Cancer Institute (NCI) | Phase 2 |
| Active Not Recruiting | Testing AZD5363 as a Potential Targeted Treatment in Cancers With AKT Genetic Changes (MATCH-Subprotocol Y) NCT04439123 | National Cancer Institute (NCI) | Phase 2 |
| Active Not Recruiting | Testing Palbociclib (PD-0332991) as a Potential Targeted Treatment in Cancers With CCND1, 2, 3 Amplification ( NCT04439201 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Testing Nivolumab as a Potential Targeted Treatment in Cancers With Mismatch Repair Deficiency (MATCH-Subproto NCT04439214 | National Cancer Institute (NCI) | Phase 2 |
| Recruiting | Salvage Radiation Therapy in Treating Patients With Metastatic Cancer That Has Progressed After Systemic Immun NCT02710253 | M.D. Anderson Cancer Center | Phase 2 |
| Active Not Recruiting | Testing GSK2636771 as a Potential Targeted Treatment in Cancers With PTEN Genetic Changes (MATCH-Subprotocol N NCT04439149 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Carvedilol in Preventing Heart Failure in Childhood Cancer Survivors NCT02717507 | Children's Oncology Group | Phase 2 |
| Active Not Recruiting | Testing GSK2636771 as a Potential Targeted Treatment in Cancers With PTEN Loss of Expression (MATCH-Subprotoco NCT04439188 | National Cancer Institute (NCI) | Phase 2 |
| Terminated | Genetically Modified T-Cell Therapy in Treating Patients With Advanced ROR1+ Malignancies NCT02706392 | Fred Hutchinson Cancer Center | Phase 1 |
| Active Not Recruiting | Testing Trametinib as a Potential Targeted Treatment in Cancers With GNAQ or GNA11 Genetic Changes (MATCH-Subp NCT04439357 | National Cancer Institute (NCI) | Phase 2 |
| Active Not Recruiting | Testing GDC-0032 (Taselisib) as a Potential Targeted Treatment in Cancers With PIK3CA Genetic Changes (MATCH-S NCT04439175 | National Cancer Institute (NCI) | Phase 2 |
| Withdrawn | Testing Dasatinib as a Potential Targeted Treatment in Cancers With DDR2 Genetic Changes (MATCH-Subprotocol X) NCT04439305 | National Cancer Institute (NCI) | Phase 2 |
| Active Not Recruiting | Testing Trametinib as a Potential Targeted Treatment in Cancers With NF1 Genetic Changes (MATCH-Subprotocol S1 NCT04439318 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Evaluation of Satisfaction With Quality of Care on the Palliative Care Unit NCT02686411 | M.D. Anderson Cancer Center | — |
| Active Not Recruiting | Testing AZD9291 as Potentially Targeted Treatment in Cancers With EGFR Genetic Changes (MATCH-Subprotocol E) NCT06303167 | National Cancer Institute (NCI) | Phase 2 |
| Active Not Recruiting | Testing VS-6063 (Defactinib) as a Potential Targeted Treatment in Cancers With NF2 Genetic Changes (MATCH-Subp NCT04439331 | National Cancer Institute (NCI) | Phase 2 |
| Recruiting | Non-invasive Ventilation in Reducing the Need for Intubation in Patients With Cancer and Respiratory Failure NCT02464696 | M.D. Anderson Cancer Center | N/A |
| Active Not Recruiting | Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymph NCT02465060 | National Cancer Institute (NCI) | Phase 2 |
| Active Not Recruiting | Testing Afatinib as a Potential Targeted Treatment in Cancers With HER2 Genetic Changes (MATCH-Subprotocol B) NCT04439136 | National Cancer Institute (NCI) | Phase 2 |
| Active Not Recruiting | Testing Crizotinib as a Potential Targeted Treatment in Cancers With ALK Genetic Changes (MATCH-Subprotocol F) NCT04439266 | National Cancer Institute (NCI) | Phase 2 |
| Active Not Recruiting | Testing Trametinib as a Potential Targeted Treatment in Cancers With BRAF Genetic Changes (MATCH-Subprotocol R NCT04439279 | National Cancer Institute (NCI) | Phase 2 |
| Active Not Recruiting | Testing Trametinib and Dabrafenib as a Potential Targeted Treatment in Cancers With BRAF Genetic Changes (MATC NCT04439292 | National Cancer Institute (NCI) | Phase 2 |
| Active Not Recruiting | Testing Crizotinib as a Potential Targeted Treatment in Cancers With ROS1 Genetic Changes (MATCH-Subprotocol G NCT04439253 | National Cancer Institute (NCI) | Phase 2 |
| Active Not Recruiting | Testing Ado-Trastuzumab Emtansine as a Potential Targeted Treatment in Cancers With HER2 Genetic Changes (MATC NCT04439110 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Vaccine Therapy in Reducing the Frequency of Cytomegalovirus Events in Patients With Hematologic Malignancies NCT02396134 | City of Hope Medical Center | Phase 2 |
| Active Not Recruiting | Donor Cytomegalovirus-Specific Cytotoxic T-Lymphocytes in Treating Patients With a Persistent Cytomegalovirus NCT02210078 | M.D. Anderson Cancer Center | Phase 2 |
| Active Not Recruiting | Cognitive Behavioral Therapy and Multimodal Therapy in Treating Sleep Disturbance in Patients With Cancer NCT01628029 | M.D. Anderson Cancer Center | Phase 2 |
| Completed | Lenalidomide and Ipilimumab After Stem Cell Transplant in Treating Patients With Hematologic or Lymphoid Malig NCT01919619 | M.D. Anderson Cancer Center | Phase 2 |
| Completed | Uprosertib, Dabrafenib, and Trametinib in Treating Patients With Stage IIIC-IV Cancer NCT01902173 | National Cancer Institute (NCI) | Phase 1 / Phase 2 |
| Completed | INSPIRE: Internet and Social-media Program With Information and Resources for Long-Term Cancer Survivors Who U NCT01602211 | Fred Hutchinson Cancer Center | Phase 3 |
| Completed | Caspofungin Acetate, Fluconazole, or Voriconazole in Preventing Fungal Infections in Patients Following Donor NCT01503515 | Children's Oncology Group | Phase 3 |
| Terminated | Donor Cord Blood T-Cell Infusion After Stem Cell Transplant in Treating Patients With Relapsed Hematological M NCT01630564 | M.D. Anderson Cancer Center | Phase 1 |
| Completed | CMC-544 and Allogeneic Transplantation for CD22 Positive-Lymphoid Malignancies NCT01664910 | M.D. Anderson Cancer Center | Phase 1 / Phase 2 |
| Completed | Romidepsin in Treating Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Solid Tumors With Liver Dysfun NCT01638533 | National Cancer Institute (NCI) | Phase 1 |
| Completed | New Magnetic Resonance Imaging and Spectroscopy Software in the Improvement of Image Quality NCT03980535 | M.D. Anderson Cancer Center | N/A |
| Recruiting | Molecular Testing for the MD Anderson Cancer Center Personalized Cancer Therapy Program NCT01772771 | M.D. Anderson Cancer Center | — |
| Completed | Sirolimus, Cyclosporine, and Mycophenolate Mofetil in Preventing Graft-versus-Host Disease in Treating Patient NCT01251575 | Fred Hutchinson Cancer Center | Phase 2 |
| Completed | Graft-Versus-Host Disease Prophylaxis in Treating Patients With Hematologic Malignancies Undergoing Unrelated NCT01231412 | Fred Hutchinson Cancer Center | Phase 3 |
| Completed | Immune Response After Stem Cell Transplant in HIV-Positive Patients With Hematologic Cancer NCT00968630 | Fred Hutchinson Cancer Center | Phase 2 |
| Completed | Azacitidine and Oxaliplatin In Treating Patients With Advanced Cancers Relapsed or Refractory to Any Platinum NCT01039155 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Veliparib and Topotecan With or Without Carboplatin in Treating Patients With Relapsed or Refractory Acute Leu NCT00588991 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Bortezomib and Chemotherapy in Treating Participants With Lymphoid Malignancies Undergoing Stem Cell Transplan NCT00439556 | M.D. Anderson Cancer Center | Phase 2 |
| Terminated | Collection of Outcomes Data for Pregnant Patients With Cancer NCT00507572 | M.D. Anderson Cancer Center | — |
| Recruiting | Data Collection for the Assessment of Acute and Late Normal Tissue in Patients Treated With Proton Therapy NCT00991094 | M.D. Anderson Cancer Center | — |
| Completed | Total-Body Irradiation With or Without Fludarabine Phosphate Followed By Donor Stem Cell Transplant in Treatin NCT00075478 | Fred Hutchinson Cancer Center | Phase 3 |